As of 2025-05-15, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 13.1x | 10.9x |
| Forward P/E multiples | 10.0x - 20.0x | 15.6x |
| Fair Price | (91.52) - (106.52) | (107.38) |
| Upside | -6878.9% - -7990.5% | -8054.0% |
| Date | EV/EBITDA |